Cargando…

Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management

The sickle hemoglobin is an abnormal hemoglobin due to point mutation (GAG → GTG) in exon 1 of the β globin gene resulting in the substitution of glutamic acid by valine at position 6 of the β globin polypeptide chain. Although the molecular lesion is a single-point mutation, the sickle gene is plei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ballas, Samir K., Kesen, Muge R., Goldberg, Morton F., Lutty, Gerard A., Dampier, Carlton, Osunkwo, Ifeyinwa, Wang, Winfred C., Hoppe, Carolyn, Hagar, Ward, Darbari, Deepika S., Malik, Punam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific World Journal 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415156/ https://www.ncbi.nlm.nih.gov/pubmed/22924029 http://dx.doi.org/10.1100/2012/949535

Ejemplares similares

Erratum to “Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management”
por: Ballas, Samir K., et al.
Publicado: (2013)

Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2020)

Intrapartum Management of Sickle Cell Anemia With Rare Antibody and Minimal Blood Availability
por: Dom, Aaron M., et al.
Publicado: (2020)

Sickle Cell Anaemia: Progress in Pathogenesis and Treatment
por: Ballas, Samir K.
Publicado: (2012)

The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease
por: Ballas, Samir K.
Publicado: (2020)

How I Treat Acute and Persistent Sickle Cell Pain
por: Ballas, Samir K.
Publicado: (2020)

Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic
por: Ballas, Samir K.
Publicado: (2021)

Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy
por: Rodrigues, Murilo, et al.
Publicado: (2016)

Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy
por: Jee, Kathleen, et al.
Publicado: (2017)

The Sixth Vital Sign: Body Mass Index in Patients With Sickle Cell Disease
por: Ballas, Samir K.
Publicado: (2017)

From Individualized Treatment of Sickle Cell Pain to Precision Medicine: A 40-Year Journey
por: Ballas, Samir K.
Publicado: (2016)

The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises
por: Ballas, Samir K.
Publicado: (2017)

Morphine for the Treatment of Pain in Sickle Cell Disease
por: Gupta, Mihir, et al.
Publicado: (2015)

Quality of life among adolescents with sickle cell disease: Mediation of pain by internalizing symptoms and parenting stress
por: Barakat, Lamia P, et al.
Publicado: (2008)

Provider Perspective on Integrative Medicine for Pediatric Sickle Cell Disease–related Pain
por: Neri, Caitlin M., et al.
Publicado: (2016)

Deafness and Sickle Cell Disease: Three Case Reports and Review of the Literature
por: Desai, Payal, et al.
Publicado: (2015)

Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high‐ and low‐ to middle‐income countries for the international Sickle Cell World Assessment Survey
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2022)

Menopause in Brazilian women with sickle cell anemia with and without hydroxyurea therapy
por: Queiroz, Ana Mach, et al.
Publicado: (2021)

Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises
por: Krishnan, Suba, et al.
Publicado: (2010)

Genetic Correction of Sickle Cell Anemia and β-Thalassemia: Progress and New Perspective
por: Perumbeti, Ajay, et al.
Publicado: (2010)

Predictors of impending acute chest syndrome in patients with sickle cell anaemia
por: Alkindi, Salam, et al.
Publicado: (2020)

Vitamin D levels are low in adult patients with sickle cell disease in Jamaica and West Africa
por: Tayo, Bamidele O, et al.
Publicado: (2014)

Elevated Circulating Angiogenic Progenitors and White Blood Cells Are Associated with Hypoxia-Inducible Angiogenic Growth Factors in Children with Sickle Cell Disease
por: Ofori-Acquah, Solomon F., et al.
Publicado: (2012)

O-03: ETAVOPIVAT TREATMENT FOR UP TO 12 WEEKS IN PATIENTS WITH SICKLE CELL DISEASE IS WELL TOLERATED AND IMPROVES RED BLOOD CELL HEALTH
por: M., TELEN, et al.
Publicado: (2022)

Time to rethink haemoglobin threshold guidelines in sickle cell disease
por: Ballas, Samir K., et al.
Publicado: (2021)

Patient-reported outcomes in children with sickle cell disease at presentation for an acute pain episode
por: Bakshi, Nitya, et al.
Publicado: (2022)

Cognitive Testing of an Electronic Version of the Faces Pain Scale-Revised with Pediatric and Adolescent Sickle Cell Patients
por: Gupta, Neehar, et al.
Publicado: (2016)

Reduction in vaso-occlusive events following stem cell transplantation in patients with sickle cell disease
por: Leonard, Alexis, et al.
Publicado: (2022)

Maternal and perinatal outcomes in pregnant women with sickle cell disease: an update
por: Sousa, Viviane Teixeira de, et al.
Publicado: (2022)

P-065: IMPACT OF SOCIOECONOMIC FACTORS ON COGNITIVE FUNCTION IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE
por: A., DARBARI, et al.
Publicado: (2022)

Survival Probability in Patients with Sickle Cell Anemia Using the Competitive Risk Statistical Model
por: do Nascimento, Emilia Matos, et al.
Publicado: (2019)

S109: ACTIVATION OF PYRUVATE KINASE-R WITH ETAVOPIVAT (FT-4202) IS WELL TOLERATED, IMPROVES ANEMIA, AND DECREASES INTRAVASCULAR HEMOLYSIS IN PATIENTS WITH SICKLE CELL DISEASE TREATED FOR UP TO 12 WEEKS
por: Telen, M, et al.
Publicado: (2022)

P1495: ETAVOPIVAT TREATMENT FOR UP TO 12 WEEKS IN PATIENTS WITH SICKLE CELL DISEASE IS WELL TOLERATED AND IMPROVES RED BLOOD CELL HEALTH
por: Saraf, S., et al.
Publicado: (2022)

Graph theory analysis reveals how sickle cell disease impacts neural networks of patients with more severe disease
por: Case, Michelle, et al.
Publicado: (2018)

Hydroxyurea and sickle cell anemia: effect on quality of life
por: Ballas, Samir K, et al.
Publicado: (2006)

Characterizing User Engagement With a Digital Intervention for Pain Self-management Among Youth With Sickle Cell Disease and Their Caregivers: Subanalysis of a Randomized Controlled Trial
por: Lalloo, Chitra, et al.
Publicado: (2022)

Sleep disturbance, depression and pain in adults with sickle cell disease
por: Wallen, Gwenyth R, et al.
Publicado: (2014)

Risk Factors of Pulmonary Hypertension in Brazilian Patients with Sickle Cell Anemia
por: Lobo, Clarisse Lopes de Castro, et al.
Publicado: (2015)

Impact of sickle cell disease on patientsʼ daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY)
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2021)

5613459 PAIN IN YOUTH WITH SICKLE CELL DISEASE AND ASSOCIATION WITH SLEEP
por: Hyppolite, R.H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rgpnq38k664rgnoah1j3s3apom